Area of Work
Analysis of prospective and retrospective studies, high-dimensional genomic data, survival data, clinical trials
Education and Background
- DKFZ/Biostatistics since May 2007
- 2004-2007 clinical trial statistician in pharmaceutical industry
- Diploma, Statistics, University of Dortmund, 2004
Selected Publications
- Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS, Jauch A, Neben K, Hose D, Egerer G, Weber MA, Delorme S, Goldschmidt H, Hillengass J: Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 28, 1902-1908, 2014.
- Neben K, Jauch A, Hielscher T, Hillengass J, Lehners N, Seckinger A, Granzow M, Raab MS, Ho AD, Goldschmidt H, Hose D: Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load. Journal of Clinical Oncology 31 (34), 4325-4332, 2013.
- Remke M*, Hielscher T*, Korshunov A, Northcott PA, Bender S, Kool M, Westermann F, Benner A, Cin H, Ryzhova M, Sturm D, Witt H, Haag D, Toedt G, Wittmann A, Schoettler A von Bueren AO, von Deimling A, Rutkowski S, Scheurlen W , Kulozik AE, Taylor MD, Lichter P, Pfister SM.: FSTL5 is a marker of poor prognosis in non-WNT/ non-SHH medulloblastoma. Journal of Clinical Oncology 29 (29), 3852-3861, 2011. (*joint first authors)
- Hielscher T*, Zucknick M*, Werft W, Benner A: On the prognostic value of survival models with application to gene expression signatures. Statistics in Medicine 29 (7-8), 818-829, 2010. (*joint first authors)
- Benner A, Zucknick M , Hielscher T, Ittrich C, Mansmann U: High-Dimensional Cox Models: The Choice of Penalty as Part of the Model Building Process. Biometrical Journal 52 (1), 50-69, 2010.